Select a medication above to begin.
Sirturo
bedaquiline
Black Box Warnings .
QT Prolongation
can occur; use w/ drugs that also prolong QT interval may cause additive QT prolongation; monitor ECG; D/C if significant ventricular arrhythmia or for QT interval >500 msec
Adult Dosing .
Dosage forms: TAB: 20 mg, 100 mg
Restricted Distribution in US
- [1-800-526-7736 for more info]
tuberculosis, pulmonary
- [multi-drug resistant]
- Dose: 400 mg PO qd x2wk, then 200 mg PO 3x/wk x22wk; Info: admin. by directly observed tx; give 3x/wk doses at least 48h apart; part of multi-drug regimen; see pkg insert for missed dose recommendations; give w/ food
- [multi-drug resistant, tx-intolerant or nonresponsive (off-label)]
- Dose: 400 mg PO qd x2wk, then 200 mg PO 3x/wk x24wk; Alt: 200 mg PO qd x8wk, then 100 mg PO qd x18wk; Info: give w/ pretomanid and linezolid; admin. by directly observed tx; give 3x/wk doses at least 48h apart; see pretomanid pkg insert for missed dose and D/C recommendations; may cont. beyond 26wk; give w/ food
- [extensively drug resistant (off-label)]
- Dose: 400 mg PO qd x2wk, then 200 mg PO 3x/wk x24wk; Alt: 200 mg PO qd x8wk, then 100 mg PO qd x18wk; Info: give w/ pretomanid and linezolid; admin. by directly observed tx; give 3x/wk doses at least 48h apart; see pretomanid pkg insert for missed dose and D/C recommendations; may cont. beyond 26wk; give w/ food
renal dosing
- [see below]
- mild-moderate impairment: no adjustment; severe impairment: not defined, caution advised, consider monitoring bedaquiline levels
- HD/PD: not defined, caution advised, consider monitoring bedaquiline levels
hepatic dosing
- [see below]
- Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: not defined, weigh risk/benefit
Peds Dosing .
- Dosage forms: TAB: 20 mg, 100 mg
Restricted Distribution in US
- [1-800-526-7736 for more info]
tuberculosis, multi-drug resistant
- [5 yo and older, 15-29 kg]
- Dose: 200 mg PO qd x2wk, then 100 mg PO 3x/wk x22wk; Info: for pts w/ pulmonary infection; admin. by directly observed tx; give 3x/wk doses at least 48h apart; part of multi-drug regimen; see pkg insert for missed dose recommendations; give w/ food
- [5 yo and older, >30 kg]
- Dose: 400 mg PO qd x2wk, then 200 mg PO 3x/wk x22wk; Info: for pts w/ pulmonary infection; admin. by directly observed tx; give 3x/wk doses at least 48h apart; part of multi-drug regimen; see pkg insert for missed dose recommendations; give w/ food
renal dosing
- [see below]
- mild-moderate impairment: no adjustment; severe impairment: not defined, caution advised, consider monitoring bedaquiline levels
- HD/PD: not defined, caution advised, consider monitoring bedaquiline levels
hepatic dosing
- [see below]
- Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: not defined, weigh risk/benefit
Contraindications / Cautions .
- hypersensitivity to drug or ingredient
- TB infection, latent
- TB infection, drug-sensitive
- TB infection, extra-pulmonary
- mycobaterial infection, non-tuberculous
- electrolyte abnormalities, uncorrected
- avoid: alcohol use
- QTc >500 msec
- caution: QT prolongation
- caution: long QT syndrome, congenital
- caution: ventricular arrhythmia
- caution: bradycardia
- caution: MI, recent
- caution: CHF
- caution: QT prolongation family hx
- caution: torsades de pointes hx
- caution: renal impairment, severe
- caution: dialysis
- caution: hepatotoxic agent use, concurrent
- caution: hepatic impairment, severe
Drug Interactions .
Overview
bedaquiline
antimycobacterial
- CYP3A4 substrate
- affected by altered gastrointestinal motility
- alters GI flora
- impairs immunomodulatory bacterial infective agent
- prolongs QT interval (known)
Contraindicated
- cisapride
- domperidone
- dronedarone
- levoketoconazole
- pimozide
- posaconazole
- thioridazine
- ziprasidone
Avoid/Use Alternative
- adagrasib
- albuterol
- albuterol inhaled
- alfuzosin
- amiodarone
- amisulpride
- amitriptyline
- anagrelide
- apalutamide
- apomorphine
- arformoterol inhaled
- arsenic trioxide
- artemether/lumefantrine
- asciminib
- asenapine
- atazanavir
- azithromycin
- BCG live intravesical
- berotralstat
- bosentan
- bremelanotide
- buprenorphine
- butalbital
- cabozantinib
- carbamazepine
- cenobamate
- ceritinib
- chloramphenicol
- chloroquine
- chlorpromazine
- cholera vaccine, live
- ciprofloxacin
- citalopram
- clarithromycin
- clofazimine
- clomipramine
- clozapine
- cobicistat
- crizotinib
- dabrafenib
- dasatinib
- degarelix
- desflurane
- desipramine
- deutetrabenazine
- dexmedetomidine
- dexmedetomidine injection
- disopyramide
- dofetilide
- donepezil
- droperidol
- efavirenz
- eliglustat
- encorafenib
- entrectinib
- enzalutamide
- ephedra
- epirubicin
- eribulin
- erythromycin
- escitalopram
- etrasimod
- etravirine
- fexinidazole
- fingolimod
- flecainide
- fluconazole
- fluorouracil
- fluoxetine
- formoterol inhaled
- foscarnet
- fosphenytoin
- fostemsavir
- gemtuzumab ozogamicin
- gepirone
- gilteritinib
- givinostat
- glasdegib
- goserelin
- granisetron
- grapefruit
- haloperidol
- histrelin
- hydrocodone
- hydroxychloroquine
- hydroxyzine
- ibutilide
- idelalisib
- iloperidone
- inotuzumab ozogamicin
- isoflurane
- itraconazole
- ivabradine
- ivosidenib
- ketoconazole
- lapatinib
- lefamulin
- lenvatinib
- leuprolide
- levalbuterol inhaled
- levofloxacin
- lofexidine
- lonafarnib
- loperamide
- lopinavir/ritonavir
- lorlatinib
- lumacaftor/ivacaftor
- lumateperone
- lurasidone
- macimorelin
- mavacamten
- mavorixafor
- mefloquine
- meperidine
- methadone
- metronidazole
- midostaurin
- mifepristone
- mirtazapine
- mitapivat
- mitotane
- mobocertinib
- modafinil
- moxifloxacin
- nafcillin
- nefazodone
- nelfinavir
- nilotinib
- ofloxacin
- oliceridine
- olodaterol inhaled
- ondansetron
- osilodrostat
- osimertinib
- oxaliplatin
- ozanimod
- pacritinib
- paliperidone
- palonosetron
- panobinostat
- pasireotide
- pazopanib
- pentamidine
- pentobarbital
- pexidartinib
- phenobarbital
- phenytoin
- pimavanserin
- pitolisant
- ponesimod
- pralsetinib
- primaquine
- primidone
- procainamide
- promethazine
- propafenone
- quetiapine
- quinidine (antiarrhythmic)
- quinidine (CYP2D6 inhibitor)
- quinine
- quizartinib
- ranolazine
- relugolix
- repotrectinib
- revumenib
- ribociclib
- rifabutin
- rifampin
- rifapentine
- rilpivirine
- ritonavir
- romidepsin
- rucaparib
- sacituzumab govitecan
- salmeterol inhaled
- selpercatinib
- sertraline
- sevoflurane
- siponimod
- solifenacin
- sorafenib
- sotalol
- sotorasib
- St. John's wort
- sunitinib
- tacrolimus
- tazemetostat
- telavancin
- terbutaline
- tetrabenazine
- tipranavir
- tolterodine
- toremifene
- tramadol
- trazodone
- triclabendazole
- trifluridine
- triptorelin
- tucatinib
- typhoid vaccine, live
- valbenazine
- vandetanib
- vardenafil
- vemurafenib
- venlafaxine
- vilanterol inhaled
- voclosporin
- voriconazole
Monitor/Modify Tx
- exenatide
Caution Advised
- dulaglutide
- fecal microbiota, live
- liraglutide
- tirzepatide
Adverse Reactions .
Serious Reactions
- all-cause mortality incl. after tx D/C (adult pts)
- QT prolongation
- hepatotoxicity
Common Reactions
- nausea
- arthralgia
- headache
- abdominal pain (peds pts)
- ALT or AST elevated
- rash
- hyperamylasemia
Safety/Monitoring .
Monitoring Parameters
electrolytes incl. Mg, Ca at baseline, then if QT prolongation risk, cont. periodically; ECG at baseline, then in 2wk, 12wk, and 24wk or if QT prolongation risk, qwk; LFTs at baseline, then in 2wk, then qmo or more frequently if pre-existing hepatic dz or concomitant hepatotoxic drug use
Pregnancy/Lactation .
Pregnancy
Clinical Summary
may use during pregnancy; no human data available; no known risk of fetal harm based on animal data at up to 6x systemic exposure
Lactation
Clinical Summary
avoid breastfeeding during tx and for at least 27.5 months after D/C; inadequate human data available, though possible risk of infant harm based on drug excretion into milk; no human data available to assess effects on milk production
Pharmacology .
Metabolism: liver; CYP450: 3A4 substrate
Excretion: feces primarily, urine (<1%); Half-life: 5.5mo
Subclass: Tuberculosis (TB)
Mechanism of Action
inhibits mycobacterial ATP synthesis (diarylquinoline)
Formulary .
No Formulary Selected
Join Now to View Patient Handouts!
Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.
Current Members: Sign In.
Pill Pictures
Join Now to View Pill Pictures!
Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.
Current Members: Sign In.